Combination drug therapy for dyslipidemia

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Current Atherosclerosis Reports

• Publication date

  1999-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S11883-999-0049-ZPMID 11122691
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid.

  2009influential reference
• Improving the adverse cardiovascular prognosis of type 2 diabetes.

  1999cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• Fish consumption and risk of sudden cardiac death.

  1998cited by this paper
• Basal non-cholesterol sterols reveal a subgroup of 4S not benefitted by simvastatin-induced decrease of recurrent coronary events

  1998cited by this paper
• Sitostanol Ester Added to Long-term Simvastatin Treatment of Coronary Patients With Low and High Basal Cholesterol Absorption

  1998cited by this paper
• Effects of Simvastatin and omega‐3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia

  1998cited by this paper
• Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study.

  1998cited by this paper
• Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia.

  1998cited by this paper
• Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

  1998cited by this paper
• Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

  1998cited by this paper
• Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults.

  1998cited by this paper
• Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction.

  1997cited by this paper
• n-3 fatty acids and serum lipoproteins: animal studies.

  1997cited by this paper
• Combination of Low-Dose Niacin and Pravastatin Improves the Lipid Profile in Diabetic Patients without Compromising Glycemic Control

  1997cited by this paper
• n-3 fatty acids and serum lipoproteins: human studies.

  1997cited by this paper
• Nicotinic Acid - The Underused Ally in the Fight against Coronary Disease

  1997cited by this paper
• The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.

  1997cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Combination Therapy with Low‐Dose Lovastatin and Niacin Is as Effective as Higher‐Dose Lovastatin

  1996cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

  1995cited by this paper
• Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest.

  1995cited by this paper
• Effects of pravastatin with niacin or magnesium on lipid levels and postprandial lipemia.

  1995cited by this paper
• Cholesterol reduction yields clinical benefit. A new look at old data.

  1995cited by this paper
• Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population.

  1995cited by this paper
• Complementary Effects of Pravastatin and Nicotinic Acid in the Treatment of Combined Hyperlipidaemia in Diabetic and Non-Diabetic Patients

  1994cited by this paper
• A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients.

  1994cited by this paper
• National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).

  1994cited by this paper
• Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia.

  1994cited by this paper
• Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia.

  1993cited by this paper
• Inhibition of exercise-induced shortening of bleeding time by fish oil in familial hypercholesterolemia (type IIa).

  1993cited by this paper
• Evaluation of the effectiveness of lipid-lowering therapy (bile acid sequestrants, niacin, psyllium and lovastatin) for treating hypercholesterolemia in veterans.

  1993cited by this paper
• Lipid Lowering and Plaque Regression New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease

  1993cited by this paper
• Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemias.

  1992cited by this paper
• Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy.

  1990cited by this paper
• Lovastatin, nicotinic acid, and rhabdomyolysis.

  1988cited by this paper
• Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

  1987cited by this paper
• Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.

  1986cited by this paper

• ISSN exercise & sports nutrition review update: research & recommendations

  2018cites this paper
• Plasma Lipidome Analysis by Liquid Chromatography-High Resolution Mass Spectrometry and Ion Mobility of Hypertriglyceridemic Patients on Extended-Release Nicotinic Acid: a Pilot Study

  2017influential citation
• Valoración nutricional de jóvenes nadadoras de natación sincronizada

  2015cites this paper
• This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon.

  2014cites this paper
• Optimizing Nutrition for Exercise and Sports

  2012cites this paper
• exercise & sport nutrition review : research & recommendations

  2010cites this paper
• Effects of amidated pectin alone and combined with cholestyramine on cholesterol homeostasis in rats fed a cholesterol-containing diet.

  2010cites this paper
• Journal of the International Society of Sports Nutrition Issn Exercise & Sport Nutrition Review: Research & Recommendations

  2010cites this paper
• Acides gras omega-3 et agent dyslipidemique pour therapie lipidique

  2005cites this paper
• Improving lipid management – to titrate, combine or switch

  2004cites this paper
• HDL-C and Triglyceride Levels: Relationship to Coronary Heart Disease and Treatment with Statins

  2004cites this paper
• Efficacy, Safety and Tolerability of Combined Low-Dose Simvastatin-Fenofibrate Treatment in Primary Mixed Hyperlipidaemia

  2004cites this paper
• ISSN Exercise & Sport Nutrition Review: Research & Recommendations

  2004cites this paper
• ISSN exercise & sport nutrition review: research & recommendations

  2004cites this paper
• Exercise and sport nutrition: A balanced perspective for exercise physiologists

  2003cites this paper
• Effects of orlistat, simvastatin, and orlistat + simvastatin in obese patients with hypercholesterolemia: a randomized, open-label trial

  2002cites this paper
• Regulation of lipid metabolism and gene expression by fenofibrate in hamsters.

  2001cites this paper